Results 1 to 10 of about 51,558 (250)

Challenges of Diphtheria Toxin Detection [PDF]

open access: yesToxins
Diphtheria toxin (DT) is the main virulence factor of Corynebacterium diphtheriae, C. ulcerans and C. pseudotuberculosis. Moreover, new Corynebacterium species with the potential to produce diphtheria toxin have also been described.
Marta Prygiel   +6 more
doaj   +4 more sources

New Corynebacterium Species with the Potential to Produce Diphtheria Toxin [PDF]

open access: yesPathogens, 2022
Only three Corynebacterium species are known to produce a lethal exotoxin called diphtheria toxin. These are C. diphtheriae, C. ulcerans and C. pseudotuberculosis.
Marta Prygiel   +5 more
doaj   +2 more sources

Mutation and Diversity of Diphtheria Toxin in Corynebacterium ulcerans [PDF]

open access: yesEmerging Infectious Diseases, 2019
Corynebacterium ulcerans infection is emerging in humans. We conducted phylogenetic analyses of C. ulcerans and C. diptheriae, which revealed diverse diphtheria toxin in C. ulcerans.
Ken Otsuji   +3 more
doaj   +2 more sources

Production of IgY polyclonal antibody against diphtheria toxin and evaluation of its neutralization effect by Vero cell assay [PDF]

open access: yesBMC Biotechnology, 2021
Background Diphtheria is a bacterial disease which is caused by Corynebacterium diphtheriae. The symptoms are due to the diphtheria toxin produced by the bacteria.
Morteza Rezaeifard   +4 more
doaj   +2 more sources

Structure of the Diphtheria Toxin at Acidic pH: Implications for the Conformational Switching of the Translocation Domain [PDF]

open access: yesToxins, 2020
Diphtheria toxin, an exotoxin secreted by Corynebacterium that causes disease in humans by inhibiting protein synthesis, enters the cell via receptor-mediated endocytosis. The subsequent endosomal acidification triggers a series of conformational changes,
Mykola V. Rodnin   +5 more
doaj   +2 more sources

Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis [PDF]

open access: yesFrontiers in Pharmacology
Many bacteria act pathogenic by the release of AB-type protein toxins that efficiently enter human or animal cells and act as enzymes in their cytosol.
Joscha Borho   +3 more
doaj   +2 more sources

BIOLOGICAL PROPERTIES AND MEDICAL APPLICATION OF DIPHTHERIA TOXIN DERIVATIVES [PDF]

open access: yesBiotechnologia Acta, 2018
The aim of the review was to analyze the literature data related to the application of a variety of diphtheria toxin derivatives. Although studies of the diphtheria toxin interaction with sensitive and resistant mammalian cells have been held for a ...
Manoilov K.Y.
doaj   +1 more source

IMMUNOBIOLOGY OF DIPHTHERIA. RECENT APPROACHES FOR THE PREVENTION, DIAGNOSIS, AND TREATMENT OF DISEASE [PDF]

open access: yesBiotechnologia Acta, 2013
Diphtheria is a highly contagious life-threatening disease caused by the toxi genic strains of Corynebacterium diphtheria, which are transformed by a bacteriophage carrying the toxin gene.
D. V. Kolybo   +6 more
doaj   +1 more source

Assay of Diphtheria Vaccine Potency by Intradermal Challenge Test

open access: yesЭпидемиология и вакцинопрофилактика, 2023
Relevance. Modern identifying potency (immunogenicity) of diphtheria toxoid tests are based on determining immunized animals resistance for administration challenge toxin or evaluation of protective antibodies level in serum.
E. I. Komarovskaya, О. V. Perelygyna
doaj   +1 more source

INTERACTION OF RECOMBINANT DIPHTHERIA TOXOIDS WITH CELLULAR RECEPTORS in vitro [PDF]

open access: yesBiotechnologia Acta, 2016
The aim of the research was to compare in vitro characteristics of reception of the natural diphtheria toxin — DT and its nontoxic recombinant analogs — toxoids.
K. Yu. Manoilov   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy